Patents by Inventor Pia Appelqvist

Pia Appelqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR CONVERSION OF LIGNOCELLULOSIC MATERIAL TO AN ORGANIC LIQUEFACTION PRODUCT
    Publication number: 20250197737
    Abstract: Lignocellulosic starting materials can be converted into an organic liquefaction product in a hydroliquefaction process by subjecting a mixture of a lignocellulosic starting material, an amorphous and unsupported sulfided nickel-molybdenum catalyst and a co-feed, to not less than a stoichiometric amount of hydrogen, elevated pressure and a temperature within the range of from 270° C. and up to but not including 350° C.
    Type: Application
    Filed: March 17, 2023
    Publication date: June 19, 2025
    Inventors: Werner Goldmann, Noora Kaisalo, Jani Kangas, Pekka Nurmi, Sami Toppinen, Martin Hedberg, Christian Bernlind, Pia Appelqvist
  • Antibacterial compounds
    Patent number: 11845725
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: December 19, 2023
    Assignee: INFEX Therapeutics Limited
    Inventors: Ian Cooper, David Orr, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell
  • ANTIBACTERIAL COMPOUNDS
    Publication number: 20230060011
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: September 16, 2022
    Publication date: February 23, 2023
    Inventors: Ian Cooper, David Orr, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell
  • 1-AMINOSULFONYL-2-CARBOXYPYRROLE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS
    Publication number: 20230018460
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: November 19, 2020
    Publication date: January 19, 2023
    Inventors: Andrew Wilkinson, Ian Cooper, David Orr, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell, James Kirkham
  • Antibacterial compounds
    Patent number: 11459296
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: October 4, 2022
    Assignee: INFEX Therapeutics Limited
    Inventors: Ian Cooper, David Orr, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell
  • Antibacterial Compounds
    Publication number: 20210230115
    Abstract: This invention relates to compounds of formula (I) and methods of treatment using the compounds. The compounds of the invention can be used in combination with antibacterial agents to treat bacterial infections. More specifically, the compounds of formula (I) can be used in combination with a class of antibacterial agents known as carbapenems. The novel compounds of the present invention are enzyme inhibitors and more particularly are metallo-?-lactamase inhibitors.
    Type: Application
    Filed: May 16, 2019
    Publication date: July 29, 2021
    Inventors: Ian Cooper, David ORR, Andrew Wilkinson, Jonathan Finlayson, Adam Bunt, Pia Appelqvist, Hans Wallberg, Fredrik Wångsell